ISPOR - EE255 Budget Impact Analysis of the Introduction of a Prognostic Prostate Genomic Biomarker Cancer Test in the Management of Localized Prostate Cancer Patients for Greece

EE255 Budget Impact Analysis of the Introduction of a Prognostic Prostate Genomic Biomarker Cancer Test in the Management of Localized Prostate Cancer Patients for Greece

Abstract

Authors

K Zisis N Nomikos K Athanasakis

Full Text Cite This Article

Back to Volume 25, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now